160 related articles for article (PubMed ID: 1671103)
1. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma.
Verrelle P; Meissonnier F; Fonck Y; Feillel V; Dionet C; Kwiatkowski F; Plagne R; Chassagne J
J Natl Cancer Inst; 1991 Jan; 83(2):111-6. PubMed ID: 1671103
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies.
Wishart GC; Plumb JA; Going JJ; McNicol AM; McArdle CS; Tsuruo T; Kaye SB
Br J Cancer; 1990 Nov; 62(5):758-61. PubMed ID: 1978783
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer.
Ro J; Sahin A; Ro JY; Fritsche H; Hortobagyi G; Blick M
Hum Pathol; 1990 Aug; 21(8):787-91. PubMed ID: 1974874
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
Dixon AR; Bell J; Ellis IO; Elston CW; Blamey RW
Br J Cancer; 1992 Sep; 66(3):537-41. PubMed ID: 1355661
[TBL] [Abstract][Full Text] [Related]
5. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine.
Sanfilippo O; Ronchi E; De Marco C; Di Fronzo G; Silvestrini R
Eur J Cancer; 1991; 27(2):155-8. PubMed ID: 1673852
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma.
Itsubo M; Ishikawa T; Toda G; Tanaka M
Cancer; 1994 Jan; 73(2):298-303. PubMed ID: 7904895
[TBL] [Abstract][Full Text] [Related]
7. The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy.
Koh EH; Chung HC; Lee KB; Lim HY; Kim JH; Roh JK; Min JS; Lee KS; Kim BS
Yonsei Med J; 1992 Jun; 33(2):137-42. PubMed ID: 1357834
[TBL] [Abstract][Full Text] [Related]
8. Detection of P-glycoprotein in squamous cell carcinomas of the head and neck.
Kelley DJ; Pavelic ZP; Gapany M; Stambrook P; Pavelic L; Gapany S; Gluckman JL
Arch Otolaryngol Head Neck Surg; 1993 Apr; 119(4):411-4. PubMed ID: 8096141
[TBL] [Abstract][Full Text] [Related]
9. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining.
Salmon SE; Grogan TM; Miller T; Scheper R; Dalton WS
J Natl Cancer Inst; 1989 May; 81(9):696-701. PubMed ID: 2565403
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissue.
Schneider J; Efferth T; Mattern J; Rodriguez-Escudero FJ; Volm M
Am J Obstet Gynecol; 1992 Mar; 166(3):825-9. PubMed ID: 1372471
[TBL] [Abstract][Full Text] [Related]
11. Expression of a multidrug resistance gene in esophageal adenocarcinoma. Correlation with response to chemotherapy and comparison with gastric adenocarcinoma.
Robey-Cafferty SS; Rutledge ML; Bruner JM
Am J Clin Pathol; 1990 Jan; 93(1):1-7. PubMed ID: 1967201
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Sinnett D; Glass DM; Peters AM
J Nucl Med; 2002 Apr; 43(4):519-25. PubMed ID: 11937596
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein expression in treated and untreated human breast cancer.
Schneider J; Bak M; Efferth T; Kaufmann M; Mattern J; Volm M
Br J Cancer; 1989 Dec; 60(6):815-8. PubMed ID: 2574987
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of pulmonary and pleural tumors with the monoclonal antibody HYB-612 directed against the multidrug resistance (MDR-1) gene product, P-glycoprotein.
Radosevich JA; Robinson PG; Rittmann-Grauer LS; Wilson B; Leung JP; Maminta ML; Warren W; Rosen ST; Gould VE
Tumour Biol; 1989; 10(5):252-7. PubMed ID: 2479079
[TBL] [Abstract][Full Text] [Related]
15. PCNA/cyclin and P-glycoprotein as prognostic factors in locally advanced breast cancer. An immunohistochemical, retrospective study.
Botti G; Chiappetta G; D'Aiuto G; de Angelis E; De Matteis A; Montella M; Picone A; Cascione F
Tumori; 1993 Jun; 79(3):214-8. PubMed ID: 7901927
[TBL] [Abstract][Full Text] [Related]
16. Detection of drug resistance and P-glycoprotein in human renal cell carcinomas.
Bak M; Efferth T; Mickisch G; Mattern J; Volm M
Eur Urol; 1990; 17(1):72-5. PubMed ID: 1969346
[TBL] [Abstract][Full Text] [Related]
17. A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.
Moran E; Larkin A; Doherty G; Kelehan P; Kennedy S; Clynes M
J Clin Pathol; 1997 Jun; 50(6):465-71. PubMed ID: 9378810
[TBL] [Abstract][Full Text] [Related]
18. Detection of P-glycoprotein in human leukemias using monoclonal antibodies.
Mattern J; Efferth T; Bak M; Ho AD; Volm M
Blut; 1989 Apr; 58(4):215-7. PubMed ID: 2565123
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.
Rose AA; Grosset AA; Dong Z; Russo C; Macdonald PA; Bertos NR; St-Pierre Y; Simantov R; Hallett M; Park M; Gaboury L; Siegel PM
Clin Cancer Res; 2010 Apr; 16(7):2147-56. PubMed ID: 20215530
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas.
Holzmayer TA; Hilsenbeck S; Von Hoff DD; Roninson IB
J Natl Cancer Inst; 1992 Oct; 84(19):1486-91. PubMed ID: 1359152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
